(S,R,S)-AHPC

 CAS No.: 1448297-52-6  Cat No.: BP-200014 4.5  

(S,R,S)-AHPC is a highly selective E3 ligase ligand designed for use in PROTAC (Proteolysis Targeting Chimera) technology. As a derivative of von Hippel-Lindau (VHL) ligand, (S,R,S)-AHPC facilitates the recruitment of VHL E3 ubiquitin ligase, enabling targeted protein ubiquitination and subsequent proteasomal degradation. Belonging to the category of E3 Ligase Ligands, (S,R,S)-AHPC is an essential chemical tool for researchers working on PROTAC drug development and targeted protein degradation platforms. Typical applications include conjugation to various target-binding moieties to develop VHL-based PROTAC molecules for studying, regulating, or degrading disease-associated proteins. This compound accelerates the discovery of next-generation therapeutics across oncology, neuroscience, and other disease areas where precise protein knockdown is paramount.

(S,R,S)-AHPC

Structure of 1448297-52-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
Ligand for E3 Ligase
Molecular Formula
C22H30N4O3S
Molecular Weight
430.56

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
100 mg $293 In stock
1 g $999 In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping
Room temperature in continental US; may vary elsewhere
IUPACName
(2S,4R)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
Synonyms
MDK7526; VH032-NH2; VHL ligand 1
Boiling Point
691.6±55.0 °C at 760 mmHg
Density
1.3±0.1 g/cm3
InChI Key
ZLOXMSNKPDWMEF-ZIFCJYIRSA-N
InChI
InChI=1S/C22H30N4O3S/c1-13-18(30-12-25-13)15-7-5-14(6-8-15)10-24-20(28)17-9-16(27)11-26(17)21(29)19(23)22(2,3)4/h5-8,12,16-17,19,27H,9-11,23H2,1-4H3,(H,24,28)/t16-,17+,19-/m1/s1
Canonical SMILES
CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)N)O

Background Introduction

(S,R,S)-AHPC is a highly specialized ligand designed for recruiting the von Hippel-Lindau (VHL) E3 ubiquitin ligase, a central component in the ubiquitin-proteasome system (UPS). VHL ligands like (S,R,S)-AHPC are widely utilized in the construction of PROTACs (Proteolysis Targeting Chimeras), enabling selective protein degradation via VHL-mediated ubiquitination pathways. The (S,R,S) stereochemistry of AHPC ensures optimal binding affinity and specificity for the VHL protein, making it a cornerstone moiety for advanced targeted protein degradation strategies.

Mechanism

(S,R,S)-AHPC functions by specifically binding to the VHL E3 ligase, facilitating its recruitment within bifunctional molecules such as PROTACs. Upon conjugation to a ligand that binds a protein of interest, the PROTAC molecule brings the target protein in proximity to the VHL E3 ligase complex. This interaction triggers polyubiquitination of the target protein, marking it for recognition and degradation by the cell's 26S proteasome. The (S,R,S)-stereochemistry is critical for maximizing potency and maintaining selectivity toward the VHL binding pocket, improving the efficacy of the resultant degraders.

Applications

(S,R,S)-AHPC is a core building block for the synthesis of VHL-based PROTACs and targeted protein degradation tools. Its robust chemical properties and well-characterized binding capacity make it an ideal choice for researchers aiming to develop next-generation degraders for basic research or therapeutic applications. Main uses include:

• Construction of VHL-recruiting PROTACs for preclinical and clinical research
• Development of chemical probes to study protein function through selective degradation
• SAR optimization in drug discovery pipelines aimed at undruggable targets
• Custom synthesis projects in academic and pharmaceutical settings
• Exploration of targeted protein degradation as an alternative to classical inhibition
• High-purity compound verified by HPLC, NMR, and LC-MS
• Consistent batch-to-batch reproducibility with complete QC documentation
• Supplied with COA, MSDS, and analytical data for traceability
• Reliable global shipping with stability-guaranteed packaging
• Dedicated technical support and optional custom synthesis service
• Demonstrates strong binding affinity to CRBN, VHL, or other E3 ligases
• Enables stable E3 ligase recruitment for targeted protein degradation
• Highly selective VHL E3 ligase ligand enables precise and efficient targeted protein degradation in PROTAC applications.
• Well-characterized structure offers reproducible results and broad compatibility with various warheads for customizable PROTAC design.
1. Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis
Siavash J Valafar Antimicrob Agents Chemother . 2021 Feb 17;65(3):e02091-20. doi: 10.1128/AAC.02091-20.
Molecular testing is rapidly becoming an integral component of global tuberculosis (TB) control. Uncommon mechanisms of resistance escape detection by these platforms and undermine our ability to contain outbreaks. This article is a systematic review of published articles that reported isoniazid (INH) resistance-conferring mutations between September 2013 and December 2019. The geneskatG,inhA, andfabG1, and the intergenic regionoxyR'-ahpCwere considered in this review. Fifty-two articles were included that described 9,306 clinical isolates (5,804 INH resistant [INHr] and 3,502 INH susceptible [INHs]) from 31 countries. The three most frequently mutated loci continue to be locus 315 ofkatG(katG315;n= 4,271), locus -15 ofinhA(inhA-15;n= 787), and locus -8 ofinhA(inhA-8; 106). However, the diagnostic value ofinhA-8 is far lower than previously thought, as it only appears in 25 (0.4%) of the INHrisolates lacking the first two mutations. I catalogued 45 new loci (29katG, nineinhA, and sevenahpC) associated with INH resistance and identified 59 loci (common to this and previous reviews) as a reliable basis for molecular diagnostics. Including all observed mutations provides a cumulative sensitivity of 85.6%. In 14.4% of resistant isolates, no mechanism of resistance was detected, making them likely to escape molecular detection, and in the case of INH monoresistance, likely to convert to multidrug-resistant TB (MDR-TB). Integrating the information cataloged in this study into current diagnostic tools is essential for combating the emergence of MDR-TB, and its exclusion can lead to an unintended selection against common mechanisms and to diversifying evolution. Observation of many low-frequency resistance-conferring mutations points to an advantage of whole-genome sequencing (WGS) for diagnostics. Finally, I provide five recommendations for future diagnostic platforms.
2. Dissecting peroxiredoxin catalysis: separating binding, peroxidation, and resolution for a bacterial AhpC
Gerardo Ferrer-Sueta, Kimberly J Nelson, Cristina M Furdui, Leslie B Poole, Derek Parsonage, P Andrew Karplus, Samantha Alley Biochemistry . 2015 Feb 24;54(7):1567-75. doi: 10.1021/bi501515w.
Peroxiredoxins make up a ubiquitous family of cysteine-dependent peroxidases that reduce hydroperoxide or peroxynitrite substrates through formation of a cysteine sulfenic acid (R-SOH) at the active site. In the 2-Cys peroxiredoxins, a second (resolving) cysteine reacts with the sulfenic acid to form a disulfide bond. For all peroxiredoxins, structural rearrangements in the vicinity of the active site cysteine(s) are necessary to allow disulfide bond formation and subsequent reductive recycling. In this study, we evaluated the rate constants for individual steps in the catalytic cycle of Salmonella typhimurium AhpC. Conserved Trp residues situated close to both peroxidatic and resolving cysteines in AhpC give rise to large changes in fluorescence during the catalytic cycle. For recycling, AhpF very efficiently reduces the AhpC disulfide, with a single discernible step and a rate constant of 2.3 × 10(7) M(-1) s(-1). Peroxide reduction was more complex and could be modeled as three steps, beginning with a reversible binding of H2O2 to the enzyme (k1 = 1.36 × 10(8) M(-1) s(-1), and k-1 = 53 s(-1)), followed by rapid sulfenic acid generation (620 s(-1)) and then rate-limiting disulfide bond formation (75 s(-1)). Using bulkier hydroperoxide substrates with higher Km values, we found that different efficiencies (kcat/Km) for turnover of AhpC with these substrates are primarily caused by their slower rates of binding. Our findings indicate that this bacterial peroxiredoxin exhibits rates for both reducing and oxidizing parts of the catalytic cycle that are among the fastest observed so far for this diverse family of enzymes.
3. Redox-dependent dynamics of a dual thioredoxin fold protein: evolution of specialized folds
Andrea Hall, Leslie B Poole, Elisar Barbar, Derek Parsonage, David Horita, P Andrew Karplus Biochemistry . 2009 Jun 30;48(25):5984-93. doi: 10.1021/bi900270w.
An enzyme system protecting bacteria from oxidative stress includes the flavoprotein AhpF and the peroxiredoxin AhpC. The N-terminal domain of AhpF (NTD), with two fused thioredoxin (Trx) folds, belongs to the hyperthermophilic protein disulfide oxidoreductase family. The NTD is distinct in that it contains a redox active a fold with a CxxC sequence and a redox inactive b fold that has lost the CxxC motif. Here we characterize the stability, the (15)N backbone relaxation, and the hydrogen-deuterium exchange properties of reduced [NTD-(SH)(2)] and oxidized (NTD-S(2)) NTD from Salmonella typhimurium. While both NTD-(SH)(2) and NTD-S(2) exhibit similar equilibrium unfolding transitions and order parameters, R(ex) relaxation terms are quite distinct with considerably more intermediate time scale motions in NTD-S(2). Hydrogen exchange protection factors show that the slowly exchanging core corresponds to residues in the b fold in both NTD-(SH)(2) and NTD-S(2). Interestingly, folded-state dynamic fluctuations in the catalytic a fold are significantly increased for residues in NTD-S(2) compared to NTD-(SH)(2). Taken together, these data demonstrate that oxidation of the active site disulfide does not significantly increase stability but results in a dramatic increase in conformational heterogeneity in residues primarily in the redox active a fold. Differences in dynamics between the two folds of the NTD suggest that each evolved a specialized function which, in the a fold, couples redox state to internal motions which may enhance catalysis and specificity and, in the b fold, provides a redox insensitive stable core.

What is the activity of (S,R,S)-AHPC?

(S,R,S)-AHPC is a VHL ligand that can be used to synthesize PROTAC molecules as part of the recruitment of Von Hippel-Lindau (VHL) proteins.

28/6/2022

PROTAC synthesis

I used (S,R,S)-AHPC as a starting material to synthesize GMB-475 and tested the level of degradation of BCR-ABL1 induced by GMB-475. The experiment is going well!

28/8/2022

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
Germany
Inquiry Basket